Name | Value |
---|---|
Revenues | 0.0K |
Cost of Revenue | 0.0K |
Gross Profit | 0.0K |
Operating Expense | 5,885.0K |
Operating I/L | -5,885.0K |
Other Income/Expense | 51.0K |
Interest Income | 0.0K |
Pretax | -5,834.0K |
Income Tax Expense | -51.0K |
Net Income/Loss | -5,783.0K |
Check-Cap Ltd. is a clinical stage medical diagnostics company that develops a capsule-based screening technology using ultra-low-dose X-rays to scan the colon for precancerous polyps and structural abnormalities. Its C-Scan system includes the C-Scan Cap for polyp detection, C-Scan Track for data collection, and C-Scan View software for data analysis and report generation. The company generates revenue through the sale of its C-Scan system and related software, providing healthcare professionals with a non-invasive and patient-friendly solution for colon screening.